MUSTANG BIO, INC. Operating Cash Flow
MUSTANG BIO, INC. (MBIO) reported Operating Cash Flow of -$1.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- MUSTANG BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$967.00K.
- MUSTANG BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.01M.
- MUSTANG BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.72M.
- MUSTANG BIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$818.00K.
- MUSTANG BIO, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$5.26M.
- MUSTANG BIO, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$11.41M.
- MUSTANG BIO, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$49.48M.
- MUSTANG BIO, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$65.07M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$967.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.98M 10-Q · filed 2026-08-05 | -$3.69M derived: sum of 3 quarters · filed 2026-08-05 | -$4.51M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$1.01M 10-Q · filed 2026-05-05 | -$2.73M derived: sum of 2 quarters · filed 2026-05-05 | -$3.54M derived: sum of 3 quarters · filed 2026-05-05 | -$4.88M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$2.54M derived: sum of 2 quarters · filed 2026-03-19 | -$3.88M derived: sum of 3 quarters · filed 2026-08-05 | -$5.26M 10-K · filed 2026-03-19 | |
| 2025-09-30 | -$818.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$2.16M derived: sum of 2 quarters · filed 2026-08-05 | -$3.55M 10-Q · filed 2025-11-07 | -$5.54M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.73M 10-Q · filed 2026-08-05 | -$4.72M derived: sum of 3 quarters · filed 2026-08-05 | -$6.48M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$1.39M 10-Q · filed 2026-05-05 | -$3.39M derived: sum of 2 quarters · filed 2026-05-05 | -$5.14M derived: sum of 3 quarters · filed 2026-05-05 | -$7.48M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$3.75M derived: sum of 2 quarters · filed 2026-03-19 | -$6.09M derived: sum of 3 quarters · filed 2026-03-19 | -$11.41M 10-K · filed 2026-03-19 | |
| 2024-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.09M derived: sum of 2 quarters · filed 2025-11-07 | -$9.41M 10-Q · filed 2025-11-07 | -$16.67M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$7.66M 10-Q · filed 2025-08-08 | -$14.91M derived: sum of 3 quarters · filed 2025-08-08 | -$26.93M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | -$5.32M 10-Q · filed 2025-05-14 | -$12.57M derived: sum of 2 quarters · filed 2025-05-14 | -$24.60M derived: sum of 3 quarters · filed 2025-05-14 | -$36.99M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$19.28M derived: sum of 2 quarters · filed 2025-03-28 | -$31.67M derived: sum of 3 quarters · filed 2025-03-28 | -$49.48M 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$12.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$24.41M derived: sum of 2 quarters · filed 2024-11-08 | -$42.22M 10-Q · filed 2024-11-08 | -$57.51M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$12.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$30.20M 10-Q · filed 2024-08-13 | -$45.49M derived: sum of 3 quarters · filed 2024-08-13 | -$61.40M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$17.81M 10-Q · filed 2024-05-15 | -$33.10M derived: sum of 2 quarters · filed 2024-05-15 | -$49.01M derived: sum of 3 quarters · filed 2024-05-15 | -$66.58M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$15.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$31.20M derived: sum of 2 quarters · filed 2024-03-11 | -$48.78M derived: sum of 3 quarters · filed 2024-03-11 | -$65.07M 10-K · filed 2024-03-11 | |
| 2022-09-30 | -$15.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$33.49M derived: sum of 2 quarters · filed 2023-11-14 | -$49.78M 10-Q · filed 2023-11-14 | -$64.48M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$17.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$33.86M 10-Q · filed 2023-08-14 | -$48.57M derived: sum of 3 quarters · filed 2023-08-14 | -$59.86M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$16.29M 10-Q · filed 2023-05-12 | -$30.99M derived: sum of 2 quarters · filed 2023-05-12 | -$42.28M derived: sum of 3 quarters · filed 2023-05-12 | -$54.38M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$25.99M derived: sum of 2 quarters · filed 2023-03-30 | -$38.09M derived: sum of 3 quarters · filed 2023-03-30 | -$53.67M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$11.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$23.38M derived: sum of 2 quarters · filed 2022-11-14 | -$38.96M 10-Q · filed 2022-11-14 | -$48.44M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$12.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$27.68M 10-Q · filed 2022-08-11 | -$37.15M derived: sum of 3 quarters · filed 2022-08-11 | -$47.27M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$15.58M 10-Q · filed 2022-05-12 | -$25.05M derived: sum of 2 quarters · filed 2022-05-12 | -$35.18M derived: sum of 3 quarters · filed 2022-05-12 | -$42.75M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$19.60M derived: sum of 2 quarters · filed 2022-03-23 | -$27.17M derived: sum of 3 quarters · filed 2022-03-23 | -$37.32M 10-K · filed 2022-03-23 | |
| 2020-09-30 | -$10.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$17.69M derived: sum of 2 quarters · filed 2021-11-12 | -$27.84M 10-Q · filed 2021-11-12 | -$37.33M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$7.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$17.72M 10-Q · filed 2021-08-16 | -$27.21M derived: sum of 3 quarters · filed 2021-08-16 | -$36.04M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$10.15M 10-Q · filed 2021-05-14 | -$19.64M derived: sum of 2 quarters · filed 2021-05-14 | -$28.47M derived: sum of 3 quarters · filed 2021-05-14 | -$37.25M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | -$9.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$18.32M derived: sum of 2 quarters · filed 2021-03-24 | -$27.10M derived: sum of 3 quarters · filed 2021-03-24 | -$33.58M 10-K · filed 2021-03-24 | |
| 2019-09-30 | -$8.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$17.61M derived: sum of 2 quarters · filed 2020-11-06 | -$24.09M 10-Q · filed 2020-11-06 | -$30.61M derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | -$8.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$15.26M 10-Q · filed 2020-08-10 | -$21.78M derived: sum of 3 quarters · filed 2020-08-10 | -$25.58M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | -$6.48M 10-Q · filed 2020-05-11 | -$13.01M derived: sum of 2 quarters · filed 2020-05-11 | -$16.81M derived: sum of 3 quarters · filed 2020-05-11 | -$20.16M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | -$6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$10.32M derived: sum of 2 quarters · filed 2020-03-16 | -$13.68M derived: sum of 3 quarters · filed 2020-03-16 | -$19.24M 10-K · filed 2020-03-16 | |
| 2018-09-30 | -$3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$7.16M derived: sum of 2 quarters · filed 2019-11-12 | -$12.72M 10-Q · filed 2019-11-12 | -$17.89M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | -$3.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$8.92M 10-Q · filed 2019-08-09 | -$14.09M derived: sum of 3 quarters · filed 2019-08-09 | -$18.86M derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | -$5.57M 10-Q · filed 2019-05-10 | -$10.73M derived: sum of 2 quarters · filed 2019-05-10 | -$15.50M derived: sum of 3 quarters · filed 2019-05-10 | -$16.48M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | -$5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$9.94M derived: sum of 2 quarters · filed 2019-03-18 | -$10.91M derived: sum of 3 quarters · filed 2019-03-18 | -$12.95M 10-K · filed 2019-03-18 | |
| 2017-09-30 | -$4.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$5.75M derived: sum of 2 quarters · filed 2018-11-13 | -$7.78M 10-Q · filed 2018-11-13 | -$10.04M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | -$974.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$3.01M 10-Q · filed 2018-08-13 | -$5.27M derived: sum of 3 quarters · filed 2018-08-13 | ||
| 2017-03-31 | -$2.04M 10-Q · filed 2018-05-14 | -$4.30M derived: sum of 2 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$4.13M 10-K · filed 2018-03-29 | |||
| 2016-09-30 | -$1.87M 10-Q · filed 2017-11-14 | ||||
| 2015-12-31 | -$1.57M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |